649 related articles for article (PubMed ID: 25103718)
1. Sustained and "sleeper" effects of group metacognitive training for schizophrenia: a randomized clinical trial.
Moritz S; Veckenstedt R; Andreou C; Bohn F; Hottenrott B; Leighton L; Köther U; Woodward TS; Treszl A; Menon M; Schneider BC; Pfueller U; Roesch-Ely D
JAMA Psychiatry; 2014 Oct; 71(10):1103-11. PubMed ID: 25103718
[TBL] [Abstract][Full Text] [Related]
2. Complementary group Metacognitive Training (MCT) reduces delusional ideation in schizophrenia.
Moritz S; Veckenstedt R; Bohn F; Hottenrott B; Scheu F; Randjbar S; Aghotor J; Köther U; Woodward TS; Treszl A; Andreou C; Pfueller U; Roesch-Ely D
Schizophr Res; 2013 Dec; 151(1-3):61-9. PubMed ID: 24183707
[TBL] [Abstract][Full Text] [Related]
3. Antipsychotic treatment beyond antipsychotics: metacognitive intervention for schizophrenia patients improves delusional symptoms.
Moritz S; Veckenstedt R; Randjbar S; Vitzthum F; Woodward TS
Psychol Med; 2011 Sep; 41(9):1823-32. PubMed ID: 21275083
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial to evaluate the efficacy of cognitive therapy for low-functioning patients with schizophrenia.
Grant PM; Huh GA; Perivoliotis D; Stolar NM; Beck AT
Arch Gen Psychiatry; 2012 Feb; 69(2):121-7. PubMed ID: 21969420
[TBL] [Abstract][Full Text] [Related]
5. Further evidence for the efficacy of a metacognitive group training in schizophrenia.
Moritz S; Kerstan A; Veckenstedt R; Randjbar S; Vitzthum F; Schmidt C; Heise M; Woodward TS
Behav Res Ther; 2011 Mar; 49(3):151-7. PubMed ID: 21276962
[TBL] [Abstract][Full Text] [Related]
6. Metacognitive training for schizophrenia: a multicentre randomised controlled trial.
Briki M; Monnin J; Haffen E; Sechter D; Favrod J; Netillard C; Cheraitia E; Marin K; Govyadovskaya S; Tio G; Bonin B; Chauvet-Gelinier JC; Leclerc S; Hodé Y; Vidailhet P; Berna F; Bertschy AZ; Vandel P
Schizophr Res; 2014 Aug; 157(1-3):99-106. PubMed ID: 24972754
[TBL] [Abstract][Full Text] [Related]
7. Metacognitive training for patients with schizophrenia: preliminary evidence for a targeted, single-module programme.
Balzan RP; Delfabbro PH; Galletly CA; Woodward TS
Aust N Z J Psychiatry; 2014 Dec; 48(12):1126-36. PubMed ID: 24159051
[TBL] [Abstract][Full Text] [Related]
8. Metacognitive therapy in people with a schizophrenia spectrum diagnosis and medication resistant symptoms: a feasibility study.
Morrison AP; Pyle M; Chapman N; French P; Parker SK; Wells A
J Behav Ther Exp Psychiatry; 2014 Jun; 45(2):280-4. PubMed ID: 24440585
[TBL] [Abstract][Full Text] [Related]
9. Metacognitive training for patients with schizophrenia (MCT): feasibility and preliminary evidence for its efficacy.
Aghotor J; Pfueller U; Moritz S; Weisbrod M; Roesch-Ely D
J Behav Ther Exp Psychiatry; 2010 Sep; 41(3):207-11. PubMed ID: 20167306
[TBL] [Abstract][Full Text] [Related]
10. Metacognitive group training for schizophrenia spectrum patients with delusions: a randomized controlled trial.
van Oosterhout B; Krabbendam L; de Boer K; Ferwerda J; van der Helm M; Stant AD; van der Gaag M
Psychol Med; 2014 Oct; 44(14):3025-35. PubMed ID: 25066223
[TBL] [Abstract][Full Text] [Related]
11. Individualized metacognitive therapy program for patients with psychosis (MCT+): introduction of a novel approach for psychotic symptoms.
Vitzthum FB; Veckenstedt R; Moritz S
Behav Cogn Psychother; 2014 Jan; 42(1):105-10. PubMed ID: 23631928
[TBL] [Abstract][Full Text] [Related]
12. Sustained antipsychotic effect of metacognitive training in psychosis: a randomized-controlled study.
Favrod J; Rexhaj S; Bardy S; Ferrari P; Hayoz C; Moritz S; Conus P; Bonsack C
Eur Psychiatry; 2014 Jun; 29(5):275-81. PubMed ID: 24176646
[TBL] [Abstract][Full Text] [Related]
13. Sowing the seeds of doubt: a narrative review on metacognitive training in schizophrenia.
Moritz S; Andreou C; Schneider BC; Wittekind CE; Menon M; Balzan RP; Woodward TS
Clin Psychol Rev; 2014 Jun; 34(4):358-66. PubMed ID: 24866025
[TBL] [Abstract][Full Text] [Related]
14. Metacognitive training for delusion in treatment-resistant schizophrenia.
Kumar D; Rao MG; Raveendranathan D; Venkatasubramanian G; Varambally S; Gangadhar BN
Clin Schizophr Relat Psychoses; 2015 Apr; 9(1):40-3. PubMed ID: 23518783
[TBL] [Abstract][Full Text] [Related]
15. Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior.
Hogarty GE; Flesher S; Ulrich R; Carter M; Greenwald D; Pogue-Geile M; Kechavan M; Cooley S; DiBarry AL; Garrett A; Parepally H; Zoretich R
Arch Gen Psychiatry; 2004 Sep; 61(9):866-76. PubMed ID: 15351765
[TBL] [Abstract][Full Text] [Related]
16. The influence of metacognitive training on delusion severity and metacognitive ability in schizophrenia.
Erawati E; Keliat BA; Helena N; Hamid A
J Psychiatr Ment Health Nurs; 2014; 21(9):841-7. PubMed ID: 24548341
[TBL] [Abstract][Full Text] [Related]
17. Investigating the efficacy of an individualized metacognitive therapy program (MCT+) for psychosis: study protocol of a multi-center randomized controlled trial.
Schneider BC; Brüne M; Bohn F; Veckenstedt R; Kolbeck K; Krieger E; Becker A; Drommelschmidt KA; Englisch S; Eisenacher S; Lee-Grimm SI; Nagel M; Zink M; Moritz S
BMC Psychiatry; 2016 Feb; 16():51. PubMed ID: 26921116
[TBL] [Abstract][Full Text] [Related]
18. Effect of Adjunctive Raloxifene Therapy on Severity of Refractory Schizophrenia in Women: A Randomized Clinical Trial.
Kulkarni J; Gavrilidis E; Gwini SM; Worsley R; Grigg J; Warren A; Gurvich C; Gilbert H; Berk M; Davis SR
JAMA Psychiatry; 2016 Sep; 73(9):947-54. PubMed ID: 27438995
[TBL] [Abstract][Full Text] [Related]
19. The retinoid X receptor agonist bexarotene relieves positive symptoms of schizophrenia: a 6-week, randomized, double-blind, placebo-controlled multicenter trial.
Lerner V; Miodownik C; Gibel A; Sirota P; Bush I; Elliot H; Benatov R; Ritsner MS
J Clin Psychiatry; 2013 Dec; 74(12):1224-32. PubMed ID: 24434091
[TBL] [Abstract][Full Text] [Related]
20. Cognitive therapy for people with a schizophrenia spectrum diagnosis not taking antipsychotic medication: an exploratory trial.
Morrison AP; Hutton P; Wardle M; Spencer H; Barratt S; Brabban A; Callcott P; Christodoulides T; Dudley R; French P; Lumley V; Tai SJ; Turkington D
Psychol Med; 2012 May; 42(5):1049-56. PubMed ID: 21914252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
